Search by Drug Name or NDC

    NDC 67877-0501-90 Amlodipine and olmesartan Medoxomil 5; 40 mg/1; mg/1 Details

    Amlodipine and olmesartan Medoxomil 5; 40 mg/1; mg/1

    Amlodipine and olmesartan Medoxomil is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL.

    Product Information

    NDC 67877-0501
    Product ID 67877-501_769ea6a3-3337-4ff2-8674-0b5dc1483f47
    Associated GPIs 36993002050320
    GCN Sequence Number 063181
    GCN Sequence Number Description amlodipine bes/olmesartan med TABLET 5 MG-40 MG ORAL
    HIC3 A4H
    HIC3 Description ANGIOTENSIN RECEPTOR BLOCKR-CALCIUM CHANNEL BLOCKR
    GCN 98938
    HICL Sequence Number 035042
    HICL Sequence Number Description AMLODIPINE BESYLATE/OLMESARTAN MEDOXOMIL
    Brand/Generic Generic
    Proprietary Name Amlodipine and olmesartan Medoxomil
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine and olmesartan Medoxomil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5; 40
    Active Ingredient Units mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209042
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0501-90 (67877050190)

    NDC Package Code 67877-501-90
    Billing NDC 67877050190
    Package 90 TABLET in 1 BOTTLE (67877-501-90)
    Marketing Start Date 2017-08-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.44697
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description AMLODIPINE-OLMESARTAN 5-40 MG
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis